These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9767874)

  • 1. [The prescription of serum tumor markers in a general hospital].
    Watine J; Charet JC; Augé MC
    Presse Med; 1998 May; 27(18):862, 864. PubMed ID: 9767874
    [No Abstract]   [Full Text] [Related]  

  • 2. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
    De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomarkers and IL-2R in lung cancer.
    Marino P; Preatoni A; Fonticoli L; Parodi M; Tarolo GL
    Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of neuron-specific enolase, carbohydrate antigen 19-9 and carbohydrate antigen 125 in carcinoma of the lung.
    Oktay G; Güner G; Karlikaya C; Akkoçlu A
    Biochem Soc Trans; 1995 May; 23(2):211S. PubMed ID: 7672232
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic and diagnostic usefulness of serum markers in lung cancer.
    Stahel RA; Martz G
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):893-4. PubMed ID: 2822425
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum neurone-specific enolase and other neuroendocrine markers in lung cancer.
    Ledermann JA
    Eur J Cancer; 1994; 30A(5):574-6. PubMed ID: 8080666
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic markers for stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N
    Lung Cancer; 2008 Feb; 59(2):274-5. PubMed ID: 18055061
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
    Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of carcinoembryonic antigen (CEA) and brain-type creatine kinase (CK-BB) in serum from patients with carcinoma of the lung.
    Nikliński J; Furman M; Laudański J; Pałynyczko Z; Welk M
    Neoplasma; 1991; 38(2):129-35. PubMed ID: 1645850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer].
    Zhang ZF; Ma JQ; Sun N; Zhang L
    Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):817-9. PubMed ID: 15363304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of neuron specific enolase and tissue polipeptidic antigen for the management of patients with lung cancer.
    Spinazzi A; Soresi E; Borghini U; Boffi R; Vigorelli R; Scoccia S
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):141-5. PubMed ID: 1965446
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of determination of the serum carcinoembryonic antigen in oncopulmonology].
    Lazarev SM; Reshetov AV; Nikolaev GV; Volgin GN; Nokhrin AV; Kokorin DM
    Vestn Khir Im I I Grek; 2009; 168(3):21-5. PubMed ID: 19663274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors confounding evaluation of treatment effect in lung cancer.
    Osterlind K
    Lung Cancer; 1994 Mar; 10 Suppl 1():S97-103. PubMed ID: 8087532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
    Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A
    Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
    Chen X; Wang X; He H; Liu Z; Hu JF; Li W
    PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thymidine kinase in diagnosis and follow-up of the small cell carcinoma of the lung.
    Abbasciano V; Graziano L; Arcudi D; Felisatti G; Cavallini AR; Reali MG; Calia N; Campi S; Guglielmini C
    Med Oncol Tumor Pharmacother; 1991; 8(1):29-34. PubMed ID: 1645826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease.
    Nowak K; Rafat N; Belle S; Weiss C; Hanusch C; Hohenberger P; Beck GCh
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):758-63. PubMed ID: 19896859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G; Ferrigno D
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.